Poliomyelitis Vaccine

Drug #973

Poliomyelitis Vaccine is a sterile aqueous suspension of suitable strains of poliomyelitis virus types1, 2 and 3 grown in suitable cell cultures. Poliomyelitis Vaccine is used for active immunization against infection of poliomyelitis caused by polio virus in infants of 6 to 12 week, children and adults 18 years of age.

← Previous drug Next drug →

Primary Characteristics

It is of Natural origin and belongs to .

It is classified in Live Attenuated Polio Virus pharmacological group. It is also classified under Vaccines .

Solubility in Water: null · Solubility in Alcohol: null · Non-proprietary name: Poliomyelitis Vaccine.

Molecular structure of Poliomyelitis Vaccine

Pharmacokinetics

Distribution: Poliomyelitis Vaccine has a volume of distribution is . plasma protein binding is .

Elimination: it is metabolised via , plasma half-life is , renal excretion is .

Indications

Poliomyelitis Vaccine is primarily indicated in conditions like Prevention of poliomyelitis.

Contraindications

Poliomyelitis Vaccine is contraindicated in conditions like Febrile illness, Impaired immune responses.

Dosage

Poliomyelitis Vaccine's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
2.5 drops	2.5 drops	—	PO	At birth then at 6, 10 and 14 weeks of life. then with boosters at 18 months and 5 years.
Paediatric Dosage (20kg)
0.125 ml	0.125 ml	—	Oral	Once or As Required
Neonatal Dosage (3kg)
0.5 ml	0.5 ml	—	Oral	As required

Drug Interactions

Unknown1 interaction

2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Poliomyelitis Vaccine is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Headache, Vomiting .

Warnings / Precautions

Vaccination should be postponed in patients suffering from any acute illness. Immunization should not be carried out in individuals who have previously had a severe local or general reaction to the vaccine. Some vaccine contains antibiotics in small amount and should not be given to patients with history of anaphylaxis to the agent used. It should be given atleast 10days before starting immunosuppressive therapy be delayed until atleast 6 months after completion of therapy. It is not recommended to use in children under 2yr of age.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Drops

0.1 ml

Inj

0.1 ml

Storage Conditions

Poliomyelitis Vaccine should be stored Susp, Soln.

Drug Classification

1.19.3.1 — Vaccines for universal immunization

Manufacturers

Manufacturers of Poliomyelitis Vaccine in Pakistan:

Amson Novartis SMS